Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

Ernafil Tablet 100 mg

Approval Number

SIN14151P

Drug Name

Ernafil Tablet 100 mg

Product Name

Ernafil Tablet 100 mg

Approval Date

May 18, 2012

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

G04BE03

ATC Item Name

sildenafil

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

Actavis Ltd.

Active Ingredients

Ingredient Name

Sildenafil citrate 140.48 mg corresponding to sildenafil base

Strength

100.00 mg

Drug MonographSildenafil

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy